Literature DB >> 22801550

Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm.

Tak-hong Cheung1, Kwun-nok Mimi Man, Mei-yung Yu, So-fan Yim, Nelson S S Siu, Keith W K Lo, Graeme Doran, Raymond R Y Wong, Vivian W Wang, David I Smith, Michael J Worley, Ross S Berkowitz, Tony K H Chung, Yick-fu Wong.   

Abstract

MicroRNAs (miRNAs) play an important role in a variety of physiological as well as pathophysiological processes, including carcinogenesis. The aim of this study is to identify a distinct miRNA expression signature for cervical intraepithelial neoplasia (CIN) and to unveil individual miRNAs that may be involved in the development of cervical carcinoma. Expression profiling using quantitative real-time RT-PCR of 202 miRNAs was performed on micro-dissected high-grade CIN (CIN 2/3) tissues and compared to normal cervical epithelium. Unsupervised hierarchical clustering of the miRNA expression pattern displayed a distinct separation between the CIN and normal cervical epithelium samples. Supervised analysis identified 12 highly differentially regulated miRNAs, including miR-518a, miR-34b, miR-34c, miR-20b, miR-338, miR-9, miR-512-5p, miR-424, miR-345, miR-10a, miR-193b and miR-203, which distinguished the high-grade CIN specimens from normal cervical epithelium. This miRNA signature was further validated by an independent set of high-grade CIN cases. The same characteristic signature can also be used to distinguish cervical squamous cell carcinoma from normal controls. Target prediction analysis revealed that these dysregulated miRNAs mainly control apoptosis signaling pathways and cell cycle regulation. These findings contribute to understanding the role of microRNAs in the pathogenesis and progression of cervical neoplasm at the molecular level.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801550     DOI: 10.4161/cc.21278

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  43 in total

Review 1.  Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions.

Authors:  Renske D M Steenbergen; Peter J F Snijders; Daniëlle A M Heideman; Chris J L M Meijer
Journal:  Nat Rev Cancer       Date:  2014-06       Impact factor: 60.716

2.  Meta-analysis of microRNA expression profiling studies in human cervical cancer.

Authors:  Mei-Yi Li; Xiao-Xia Hu
Journal:  Med Oncol       Date:  2015-04-24       Impact factor: 3.064

Review 3.  HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers.

Authors:  Marina Di Domenico; Giancarlo Giovane; Soumaya Kouidhi; Rosamaria Iorio; Maurizio Romano; Francesco De Francesco; Antonia Feola; Camilla Siciliano; Luigi Califano; Antonio Giordano
Journal:  Cancer Biol Ther       Date:  2018-05-14       Impact factor: 4.742

Review 4.  Dysregulation of microRNA expression in human cervical preneoplastic and neoplastic lesions.

Authors:  Ádám Galamb; Márta Benczik; Balázs Zinner; Eszter Vígh; Kornélia Baghy; Csaba Jeney; András Kiss; Gábor Lendvai; Gábor Sobel
Journal:  Pathol Oncol Res       Date:  2015-01-20       Impact factor: 3.201

5.  Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.

Authors:  Fang Yuan; Ruifen Sun; Peng Chen; Yundan Liang; Shanshan Ni; Yi Quan; Juan Huang; Lin Zhang; Linbo Gao
Journal:  Tumour Biol       Date:  2015-11-30

6.  NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells.

Authors:  Alice Y Chuang; Jim C Chuang; Zili Zhai; Feng Wu; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

7.  microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation.

Authors:  Yi Shen; Dongfang Tang; Ruyong Yao; Mingzhao Wang; Yongjie Wang; Yasai Yao; Xiaoxiao Li; Haiping Zhang
Journal:  Med Oncol       Date:  2013-11-06       Impact factor: 3.064

8.  Prognostic significance of microRNA expression in completely resected lung adenocarcinoma and the associated response to erlotinib.

Authors:  Guanzhong Yan; Ruyong Yao; Dongfang Tang; Tong Qiu; Yi Shen; Wenjie Jiao; Nan Ge; Yunpeng Xuan; Yongjie Wang
Journal:  Med Oncol       Date:  2014-09-06       Impact factor: 3.064

9.  Hypermethylation of miR-203 in endometrial carcinomas.

Authors:  Yi-Wen Huang; Chieh-Ti Kuo; Jo-Hsin Chen; Paul J Goodfellow; Tim H-M Huang; Janet S Rader; Denise S Uyar
Journal:  Gynecol Oncol       Date:  2014-02-14       Impact factor: 5.482

10.  Low folate levels are associated with methylation-mediated transcriptional repression of miR-203 and miR-375 during cervical carcinogenesis.

Authors:  Min Hao; Weihong Zhao; Lili Zhang; Honghong Wang; Xin Yang
Journal:  Oncol Lett       Date:  2016-04-18       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.